CardioMech
CardioMech AS is a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology. Their device is an artificial chord designed to reduce or eliminate regurgitation and restore native anatomy, offering a less-invasive alternative to open-heart surgery for mitral regurgitation patients. This catheter-based therapy aims to improve the standard of care for millions suffering from this condition.
Funding Round:
Funding Amount: $13M
Date: 02-Jan-2024
Investors: existing investors, new investors, a non-disclosed strategic investor
Markets: Medical Device, Cardiovascular, Surgical Devices, HealthTech
HQ: Trondheim, Norway
Founded: 2015
Website: https://www.cardiomech.com/
Leave a Comment
Comments
No comments yet.